Loading…

Phase I/II study of high dose pomalidomide with G‐CSF support and dexamethasone in patients with relapsed/refractory multiple myeloma

Saved in:

Bibliographic Details
Published in:	American journal of hematology 2020-09, Vol.95 (9), p.E232-E235
Main Authors:	Manasanch, Elisabet E., Jain, Preetesh, Chen, Wendy, Oriabure, Onyeka, Badillo, Maria, Feng, Lei, Berkova, Zuzana, Orlowski, Robert Z., Wang, Michael
Format:	Article
Language:	English
Subjects:	Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols - administration & dosage Dexamethasone Dexamethasone - administration & dosage Disease-Free Survival Female Granulocyte Colony-Stimulating Factor - administration & dosage Hematology Humans Male Middle Aged Multiple myeloma Multiple Myeloma - drug therapy Multiple Myeloma - mortality Recurrence Steroids Survival Rate Thalidomide - administration & dosage Thalidomide - analogs & derivatives
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!